Despite the benefit for most patients, some patients have poor outcome after transcatheter aortic valve implantation (TAVI). Currently it is hard to predict which patient is predisposed to poor outcome at one year. This paper investigates the performance of a previously developed prediction model of poor outcome after TAVI.
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Predicting Quality of Life at 1 Year After Transcatheter Aortic Valve Replacement in a Real-World Population
October 14, 2018
September 25, 2018
This multicenter study evaluated the efficacy of medical therapy plus transcatheter valve repair (MitraClip) to medical therapy alone for heart failure accompanied by secondary moderate to severe mitral regurgitation. The device group experienced significantly fewer hospitalizations and lower mortality at 24 months follow-up.
July 28, 2018
The US Centers for Medicare and medicaid Services (CMS) convened a panel on 07/25/2018 to discuss recommendations for hospitals to maintain and begin TAVR programs. The focus of the discussion was the procedural volume requirements for TAVR, SAVR, and PCI (
In Global News: World Lung Cancer Day, Percutaneous Tricuspid Repairs, and a Notebook for Cancer Treatment Management
July 27, 2018
Patient Care and General Interest
In Global News: Endocarditis in Illicit Drug Users, ERAS Cardiac Surgery Consensus Statement, and NSCLC Upstaging
May 4, 2018
Patient Care and General Interest An article in the New York Times looks at the ethical dilemma of performing surgery for endocarditis in illicit drug users whose addictions go untreated.
April 13, 2018
Patient Care Michael Mack and Alec Vahanian discuss the state and future of transcatheter mitral valve replacement.
April 3, 2018
Dr Om Prakesh Yadava of the National Heart Institute in New Delhi, India, and Professor Vinayak Bapat of Columbia University in New York, USA, discuss transcatheter valve therapies and sutureless valves.
March 31, 2018
70-year-old Arnold Schwarzenegger has undergone successful redo heart surgery at Ceders-Sinai Hospital, after an initial attempt to replace his pulmonic valve percutaneously. He famously underwent an attempted Ross Procedure in 1997, and the pulmonic valve left from that operation now required repeat surgery.
The Association of Tricuspid Regurgitation With Transcatheter Aortic Valve Replacement Outcomes: A Report From The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry
March 3, 2018
The STS/ACC TAVR Registry was analyzed to determine the effect of tricuspid regurgitation (TR) on outcomes after transcatheter aortic valve replacement (TAVR). The authors found that TR, of any severity, is quite common in TAVR patients (80%). The breakup of TR severity was as follows:
February 21, 2018
A well-written, brief, pessimistic editorial on the loss of surgeon autonomy in innovation.